BSE filing, NSE: BRAWN. Summary written from the filing by ALFA Finder's alert engine.
Brawn Biotech Ltd: key numbers
- Share price
- ₹25.87
- Market cap
- ₹7.76 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 9.0×Sector 46.1×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brawn Biotech Ltd
All →Brawn Biotech Other Announcement
Brawn Biotech Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing includes details on promoter and public shareholding.
Brawn Biotech Other Announcement
Brawn Biotech Ltd members approved the appointment of M/s. GDSM and Co. as Statutory Auditors. Mr. Brij Raj Gupta was also re-appointed as Director at the Annual General Meeting.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd held its 41st Annual General Meeting on September 29, 2026. All resolutions were passed by the shareholders with the requisite majority.
Brawn Biotech Other Announcement
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd has filed the notice for its 41st Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.
Brawn Biotech Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY
Brawn Biotech Ltd reported revenue from operations of ₹6.1 Cr (+5.2% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · +0.0% YoY
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.